FOXO1A is a target for HER2-overexpressing breast tumors. [electronic resource]
Producer: 20100809Description: 5475-85 p. digitalISSN:- 1538-7445
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- pharmacology
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor
- Chromones -- pharmacology
- Down-Regulation
- Drug Synergism
- Enzyme Activation
- Enzyme Inhibitors -- pharmacology
- Female
- Forkhead Box Protein O1
- Forkhead Transcription Factors -- biosynthesis
- Gene Expression Regulation, Neoplastic
- Humans
- Morpholines -- pharmacology
- Phosphatidylinositol 3-Kinases -- metabolism
- Phosphoinositide-3 Kinase Inhibitors
- Proto-Oncogene Proteins c-akt -- antagonists & inhibitors
- RNA, Messenger -- biosynthesis
- Receptor, ErbB-2 -- antagonists & inhibitors
- Transfection
- Trastuzumab
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.